In the fast-evolving nutraceutical landscape, the demand for clinically validated cognitive health ingredients is at an all-time high.
Somin-On™, developed by Arjuna Natural Pvt. Ltd., is the world’s first standardized Ashwagandha extract containing Sominone, a bioactive withanolide identified as the key neuroactive molecule behind Ashwagandha’s cognitive-enhancing benefits.
Download the exclusive whitepaper to explore detailed clinical findings, formulation insights, and scientific data on this next-generation cognitive ingredient..
Clinical study data from randomized, double-blind, placebo-controlled trials.
Insights into mechanisms of action — synaptic plasticity, neuroinflammation modulation, and cholinergic signaling.
Application versatility across tablets, capsules, beverages, and gummies.
Market positioning guidance for brain health, stress-cognition, and healthy ageing categories
Ingredient buyers and R&D heads seeking evidence-backed botanicals.
Formulation scientists developing next-gen nootropic or healthy ageing products.
Brand strategists and business developers exploring differentiation in the brain health space.
Somin-On™ represents a breakthrough opportunity for nutraceutical brands to deliver measurable, science-backed cognitive benefits.
[Download the Scientific Whitepaper] to uncover how Somin-On™ can power your next innovation in brain health formulations — merging Ayurvedic heritage with cutting-edge neuroscience.